You have 9 free searches left this month | for more free features.

gastroesophageal cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastro-Esophageal Cancer Trial in Copenhagen

Not yet recruiting
  • Gastro-Esophageal Cancer
    • Copenhagen, Denmark
      Rigshospitalet
    Nov 17, 2023

    Gastric or Gastroesophageal Cancer Trial in Kawasaki-shi, Chuo-ku (FPA144)

    Completed
    • Gastric or Gastroesophageal Cancer
    • Kawasaki-shi, Kanagawa, Japan
    • +1 more
    Jun 13, 2023

    GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)

    Recruiting
    • GastroEsophageal Cancer
    • Gastric Cancer
    • Tampa, Florida
      Moffitt Cancer Center
    Oct 25, 2023

    Neoadjuvant Therapy in Gastric and Gastroesophageal Cancer

    Completed
    • Patients With Locally Advanced Carcinoma of the Stomach and Oesophagogastric Junction
    • CT scan
    • (no location specified)
    Sep 13, 2023

    Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)

    Recruiting
    • Gastric Cancer
    • +10 more
    • Kyiv, Ukraine
      National Cancer Institute
    Aug 31, 2023

    Gastro-esophageal Cancer Trial (Resistance training, Protein supplement)

    Not yet recruiting
    • Gastro-esophageal Cancer
    • Resistance training
    • Protein supplement
    • (no location specified)
    Dec 15, 2022

    Esophagus Cancer, Adenocarcinoma Trial (BioXmark™)

    Recruiting
    • Esophagus Cancer, Adenocarcinoma
    • BioXmark™
    • Copenhagen, Denmark
      Rigshopitalet, Department of Surgery and Transplantation
    Nov 7, 2022

    GastroEsophageal Cancer Trial in Tampa (Fitbit Data Collection, Nutrition Counseling, Survey)

    Recruiting
    • GastroEsophageal Cancer
    • Fitbit Data Collection
    • +2 more
    • Tampa, Florida
      Moffitt Cancer Center
    Jun 29, 2022

    GastrOesophageal Tumor, Immune Microenvionnment (GOTIM)

    Not yet recruiting
    • GastroEsophageal Cancer
      • Lyon, France
        Centre Léon Bérard
      Dec 1, 2022

      Nivolumab in Treatment of Early Stage Esophageal or

      Not yet recruiting
      • Esophageal Carcinoma
      • Gastroesophageal Junction Carcinoma
        • Louisville, Kentucky
        • +2 more
        Mar 21, 2023

        GastroEsophageal Cancer, Gastric Cancer Trial in New York (Lenvatinib, Pembrolizumab)

        Recruiting
        • GastroEsophageal Cancer
        • Gastric Cancer
        • New York, New York
        • +1 more
        Aug 12, 2022

        Gastric Cancer, GastroEsophageal Cancer, Fruquintinib Trial in Nanning (Fruquintinib + SOX)

        Recruiting
        • Gastric Cancer
        • +3 more
        • Fruquintinib + SOX
        • Nanning, China
          Guangxi Medical University Cancer Hospital
        Dec 2, 2022

        Within Postoperative Wound-Healing Microenvironment in

        Recruiting
        • GastroEsophageal Cancer
        • prospective collection of surgical exudates (SEs)
        • Fairfax, Virginia
          Inova Schar Cancer Institute
        Jul 29, 2022

        Gastric and Pancreatic Cancers in Latin America

        Not yet recruiting
        • Gastric Cancer
        • +2 more
        • Observational study
        • (no location specified)
        Jun 20, 2023

        Resectable Esophageal Cancer, GastroEsophageal Cancer Trial in Madison (combination product, drug, radiation)

        Active, not recruiting
        • Resectable Esophageal Cancer
        • GastroEsophageal Cancer
        • Avelumab combined with Chemoradiation
        • +3 more
        • Madison, Wisconsin
          University of Wisconsin Carbone Cancer Center
        Mar 28, 2022

        Gastric Cancer Trial in Beijing (S-1, Trastuzumab, Oxaliplatin)

        Completed
        • Gastric Cancer
        • Beijing, Beijing, China
          Chinese Academy of Medical Sciences
        Aug 14, 2022

        GastroEsophageal Cancer, Incurable Disease Trial in Amsterdam, Utrecht (Exercise intervention, Nutrition intervention)

        Active, not recruiting
        • GastroEsophageal Cancer
        • Incurable Disease
        • Exercise intervention
        • Nutrition intervention
        • Amsterdam, Noord-Holland, Netherlands
        • +1 more
        Nov 16, 2023

        Gastro-Intestinal Cancer Trial in New Brunswick (Four week alternating FOLFOX and FOLFIRI (sFOLFOXIRI))

        Recruiting
        • Gastro-Intestinal Cancer
        • Four week alternating FOLFOX and FOLFIRI (sFOLFOXIRI)
        • Hamilton, New Jersey
        • +6 more
        Oct 24, 2022

        Stent Migration, GastroEsophageal Cancer Trial in Paris (Gastroesophageal stent placement)

        Not yet recruiting
        • Stent Migration
        • GastroEsophageal Cancer
        • Gastroesophageal stent placement
        • Paris, France
          French Society of Digestive Endoscopy
        Jun 23, 2022

        Colorectal Cancer, Gastroesophageal Cancer, Ovarian Cancer Trial (IVX037)

        Not yet recruiting
        • Colorectal Cancer
        • +2 more
        • IVX037
        • (no location specified)
        Jun 21, 2022

        Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,

        Recruiting
        • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
        • +23 more
        • Houston, Texas
          M D Anderson Cancer Center
        Oct 5, 2022

        Gastric Adenocarcinoma, GastroEsophageal Cancer Trial in Orange (Cabozantinib, Pembrolizumab)

        Recruiting
        • Gastric Adenocarcinoma
        • GastroEsophageal Cancer
        • Orange, California
          Chao Family Comprehensive Cancer Center, University of Californi
        Apr 4, 2022

        GastroEsophageal Cancer Trial in Boston (Irinotecan, Oxaliplatin, Leucovorin)

        Active, not recruiting
        • GastroEsophageal Cancer
        • Boston, Massachusetts
          Massachusetts General Hospital
        Sep 7, 2022

        Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Trial (XELOX combined with Fruquintinib and Sintilimab)

        Not yet recruiting
        • Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
        • XELOX combined with Fruquintinib and Sintilimab
        • (no location specified)
        Oct 17, 2023

        Gastric Cancer, GastroEsophageal Cancer Trial in Aurora, Colorado Springs, Highlands Ranch (Pembrolizumab, Olaparib,

        Recruiting
        • Gastric Cancer
        • GastroEsophageal Cancer
        • Aurora, Colorado
        • +2 more
        Jan 4, 2023